La Jolla Biologics Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • La Jolla Biologics's estimated annual revenue is currently $26.5M per year.(i)
  • La Jolla Biologics's estimated revenue per employee is $201,000

Employee Data

  • La Jolla Biologics has 132 Employees.(i)
  • La Jolla Biologics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$54.7M27235%N/AN/A
#2
$1.2M6N/AN/AN/A
#3
$26.3M1313%N/AN/A
#4
$35M1240%$62.5MN/A
#5
$21.9M10910%N/AN/A
#6
$137.5M684-4%N/AN/A
#7
$14.9M8616%$173MN/A
#8
$91.3M454N/AN/AN/A
#9
$64.5M321-7%N/AN/A
#10
$9.4M470%N/AN/A

Tanvex Biopharma USA, Inc is a biologic pharmaceutical product development and manufacturing organization aiming to provide high quality, value added capabilities to accelerate the introduction of biologic therapeutics to the global market.

keywords:N/A

N/A

Total Funding

132

Number of Employees

$26.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

La Jolla Biologics News

2022-03-30 - Do you really need a 2nd COVID booster shot? What you need to know

Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, told reporters at a briefing. Older people and those with...

2022-03-22 - Ultra-contagious BA.2 Omicron strain adds urgency to second booster shot

The Los Angeles County Department of Public Health will be ready to offer ... for Biologics Evaluation and Research, said in a statement.

2022-03-22 - Omicron BA.2 now dominant version of coronavirus in U.S.

... director of the Scripps Research Translational Institute in La Jolla. ... director of the FDA's Center for Biologics Evaluation and...

2019-09-12 - Reviewing Dare Bioscience Inc. (DARE)'s and Synthetic Biologics Inc. (NYSEAMERICAN:SYN)'s results

Both Dare Bioscience Inc. (NASDAQ:DARE) and Synthetic Biologics Inc. ... The company was incorporated in 2015 and is based in La Jolla, ...

2019-09-12 - Synthorx to Present at the 2019 World Congress of Inflammation

... a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. ... Synthorx is headquartered in La Jolla, Calif.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$15.8M13236%N/A
#2
$26.4M1320%N/A
#3
$7.5M1320%N/A
#4
$19.3M13315%N/A
#5
$26.7M13319%N/A